AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VALERIAN
5 registrations across 3 African markets— 5 active
Markets with VALERIAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CALMETTES NITE 125 MG TABLET; ORAL | 🇿🇼Zimbabwe | ABBOTT LABORATORIES SA (PTY) LTD | active | Dec 2027 |
| CALMETTES NITE 45 MG TABLET; ORAL | 🇿🇼Zimbabwe | ABBOTT LABORATORIES SA (PTY) LTD | active | Dec 2027 |
| CALMETTES | 🇿🇦South Africa | Abbott Laboratories S.A. (Pty) Ltd | active | Jan 1900 |
| Valerian Coated Tablet | 🇰🇪Kenya | X-Centric Limited | active | — |
| VALERIAN Tablet | 🇰🇪Kenya | X-Centric Limited | active | — |
VALERIAN in Africa — Regulatory Overview
VALERIAN is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Zimbabwe, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.